Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men
Journal Article
·
· Journal of Nuclear Medicine; (USA)
OSTI ID:6321629
- Rambam Medical Center, Haifa (Israel)
Tumor concentrations of the chemotherapeutic drug, bleomycin, labeled with cobalt-57 (Co-bleo) were compared in mouse tumor models and in human lung tumors using quantitative single-photon emission computed tomography. Drug concentrations in histologically similar human tumors showed marked variability for the same injected dose (ID). Small cell carcinomas showed concentrations between 1.09 and 8.85 %ID/cc x 10(-3) while non-small cell lung tumors showed a concentration variation between 0.36 and 6.75 %ID/cc x 10(-3). In contrast to the situation in human tumors, uptake in mouse tumors showed only slight variability in animals with the same tumor model. EMT-6 tumors in mice showed at 6 hr significantly higher uptake of Co-bleo (p less than 0.001) and significantly higher tumor-to-lung ratio (p less than 0.001) when compared to murine fibrosarcomas. The EMT-6 tumors in contrast to the fibrosarcomas responded to bleomycin treatment in a dose dependent manner. The results indicate that while in mice the tumor dose closely follows the administered dose, in humans, the tumor dose and the tumor-to-lung ratio in the individual patient cannot be predicted from the administered dose.
- OSTI ID:
- 6321629
- Journal Information:
- Journal of Nuclear Medicine; (USA), Journal Name: Journal of Nuclear Medicine; (USA) Vol. 31:11; ISSN 0161-5505; ISSN JNMEA
- Country of Publication:
- United States
- Language:
- English
Similar Records
In vivo measurements of the fraction of dose of bleomycin labeled with cobalt 57 delivered to human tumors
The concentration of bleomycin labeled with Co-57 in primary and metastatic tumors
SPECT quantitation of cobalt-57 bleomycin delivery to human brain tumors
Journal Article
·
Wed May 15 00:00:00 EDT 1991
· Cancer (Philadelphia); (United States)
·
OSTI ID:5670180
The concentration of bleomycin labeled with Co-57 in primary and metastatic tumors
Journal Article
·
Fri Sep 01 00:00:00 EDT 1989
· Cancer (Philadelphia); (USA)
·
OSTI ID:5672170
SPECT quantitation of cobalt-57 bleomycin delivery to human brain tumors
Journal Article
·
Sun Jan 31 23:00:00 EST 1988
· J. Nucl. Med.; (United States)
·
OSTI ID:5172908
Related Subjects
550600 -- Medicine
550601 -- Medicine-- Unsealed Radionuclides in Diagnostics
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMITOTIC DRUGS
ANTINEOPLASTIC DRUGS
BETA DECAY RADIOISOTOPES
BLEOMYCIN
BODY
CARCINOMAS
COBALT 57
COBALT ISOTOPES
COMBINED THERAPY
COMPARATIVE EVALUATIONS
COMPUTERIZED TOMOGRAPHY
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
DOSES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
INTERMEDIATE MASS NUCLEI
ISOTOPES
LUNGS
MAMMALS
MAN
MICE
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PRIMATES
RADIATION DOSES
RADIOISOTOPES
RESPIRATORY SYSTEM
RODENTS
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
THERAPY
TOMOGRAPHY
UPTAKE
VERTEBRATES
550601 -- Medicine-- Unsealed Radionuclides in Diagnostics
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMITOTIC DRUGS
ANTINEOPLASTIC DRUGS
BETA DECAY RADIOISOTOPES
BLEOMYCIN
BODY
CARCINOMAS
COBALT 57
COBALT ISOTOPES
COMBINED THERAPY
COMPARATIVE EVALUATIONS
COMPUTERIZED TOMOGRAPHY
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
DOSES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EMISSION COMPUTED TOMOGRAPHY
INTERMEDIATE MASS NUCLEI
ISOTOPES
LUNGS
MAMMALS
MAN
MICE
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PRIMATES
RADIATION DOSES
RADIOISOTOPES
RESPIRATORY SYSTEM
RODENTS
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
THERAPY
TOMOGRAPHY
UPTAKE
VERTEBRATES